Beyond statins: New medicines for hard-to-manage cholesterol
Statins are usually the first choice to lower LDL cholesterol levels in most people who need medications, but some still fail to reach their desired targets. A new class of drugs called PCSK9 inhibitors may be able to pick up the slack.
Content restricted. Requires subscription